On average it takes about 12 to 14 months to diagnose a person with ALS after their first symptoms appear. With a disease that is often fatal within 3 to 5 years, ALS patients can’t afford to lose this time. There is an estimated $250 million market for the development of a diagnostic test that can reduce the time between first symptoms and clinical diagnosis. Amorfix recently announced their entry into this market. Amorfix is known for their development of antibodies that recognize and target misfolded SOD1. On Tuesday, January 22, Amorfix announced that they successfully completed the first steps towards developing a blood test that could be used to diagnose ALS using these antibodies that bind misfolded SOD1. Read more about the diagnostic that Amorfix is developing here.
Click here to read more.Share this: